LLY News and Press, Eli Lilly and Company From 01/01/24

2024-01-01 07:15:00 ET Eli Lilly (NYSE: LLY) has been one of the hottest healthcare stocks to own in recent years. The company is now the most valuable healthcare company in the world, with a valuation of around $550 billion. So, investors may be wondering whether the stock has peak...

2024-01-01 07:00:00 ET Summary As is usual at the start of a new year, many Seeking Alpha contributors have shared their lists of where to put your money during 2024. Not losing money with your investments is almost as important as making money. In this article, I will present...

2024-01-01 03:06:21 ET Summary Xeris Biopharma has shown strong revenue growth, from $2.7 million in 2019 to $152.7 million in the 12 months trailing to September 2023. The company's ready-to-use glucagon drug, Gvoke, has the potential for significant sales, especially in the US w...

2024-01-01 01:27:26 ET Summary Lexicon Pharmaceuticals faces a critical phase with FDA-approved Inpefa, competing against established drugs like Jardiance. Financially stable short-term, Lexicon grapples with high marketing costs and rapid cash burn, raising long-term sustainabili...

2023-12-31 12:00:33 ET More on MCOs UnitedHealth Could Be A Combination Of Dividend Growth And Capital Appreciation In 2024 UnitedHealth: A Dividend Grower To Consider For Your Portfolio Cigna: Sentiment And Fundamentals On Their Side Catalyst Watch: Macau ga...

2023-12-31 10:26:03 ET Summary Investors welcomed double-digit increases from several companies in December, including a 16% increase from Mastercard and 14% from Broadcom. 2024 will begin with announcements of dividend increases from Chevron, Archer-Daniels Midland, Fastenal, and...

2023-12-31 09:00:00 ET With cold temperatures limiting outdoor activity and scarcely any sunshine to soak up, it's natural to feel a bit sluggish during the depths of winter, and, speaking from experience, it's easy to pack on a few extra pounds during the season. In that regard, we're not ...

2023-12-31 05:36:00 ET 2023 was a great year to have money working for you in the U.S. stock market. The S&P 500 index rose about 25%, and some of its components did a whole lot better. Seasoned investors like owning shares of well-established pharmaceutical companies like Eli...

2023-12-29 15:06:27 ET More on Eli Lilly, Novo Nordisk, etc. Eli Lilly: Consider Cutting Before The Southbound Train Leaves (Rating Downgrade) Eli Lilly: Long Path To A Trillion Novo Nordisk: Latest Insights Confirm Exceptionally Bullish Opportunity Key debat...

2023-12-29 14:54:46 ET Summary I review the stocks of five world-class companies that I am convinced will bring me closer to my ambitious goal of being able to fund my living expenses through dividends. I point out the specifics of the companies' business models, discuss their pro...